Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992402 · ClinicalTrials.gov registry record · NA
Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery
A NA study of Epilepsy, sponsored by Kayela Arrotta.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05992402: Recruiting NA study of Epilepsy, sponsored by Kayela Arrotta.
NCT05992402 is a NA study of Epilepsy that is actively recruiting participants, run by Kayela Arrotta. The registered enrollment target is 64 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05992402, a NA study of Epilepsy, is actively recruiting participants, sponsored by Kayela Arrotta.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if new educational program prior to epilepsy surgery can either decrease the risk of cognitive decline after surgery or be a help to those patients who experience a decline after undergoing epilepsy surgery. Participants will participate in 2 individual virtual sessions and 4 virtual group sessions over the course of 5-6 weeks prior to their epilepsy surgery. They will asked to fill out online surveys and questionnaires at various times throughout the study, up to 12 months after their surgery. To see if the educational program works, researchers will compare those participating in the educational program with those that are receiving the standard epilepsy care prior to surgery.
Primary Outcome
As determined by weekly group attendance and the number of weeks it takes each patient to complete all four rotating sessions
Conditions Studied
Interventions
- BEHAVIORAL ReBOOT program
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT05992402 shows while recruiting
NCT05992402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which ReBOOT program is the first listed.
NCT05992402 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05992402 about?
NCT05992402 is a clinical study titled "Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery". The goal of this clinical trial is to learn if new educational program prior to epilepsy surgery can either decrease the risk of cognitive decline after surgery or be a help to those patients who experience a decline after undergoing epilepsy surgery. Participants will participate in 2 individual v...
What is the current status of trial NCT05992402?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2023-12-06. Estimated completion is 2028-06.
What conditions does trial NCT05992402 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT05992402?
The interventions under investigation include: ReBOOT program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05992402?
This trial is sponsored by Kayela Arrotta, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992402 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05992402's enrollment target sits among peer trials
64 76th of 160 higher than 84 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI